E3	Condition:T3 Name:T4
E6	Condition:T6 Name:T7
E8	Condition:T8 Name:T9
E12	Condition:T12 Name:T13
E14	Condition:T14 Name:T15
E15	Eq-Comparison:T22 Operator:T16 Value:T19 Unit:T34 Per:T35
E16	Eq-Comparison:T23 Operator:T17 Temporal-Unit:T18 Value:T20
E1	Condition:T1 Severity:T2
E2	And:T10 Arg:T5 Arg2:E1
E4	Assertion:T11 Asserted:E3
E5	And:T24 Arg:E1 Arg2:E3
E7	Or:T25 Arg:E8 Arg2:E6
E9	Allergy:T26 Name:E10 Name2:E11
E10	Drug:T27 Name:T28
E11	Drug:T29 Name:T30
E13	Or:T31 Arg:E10 Arg2:E11
E17	Observation:T32 Name:T33 Eq-Comparison:E15
E18	Drug:T36 Name:T37
E19	Drug:T39 Name:T38
E20	Drug:T40 Name:T41
E21	Drug:T42 Name:T43
E22	Drug:T44 Name:T45
E23	Or:T46 Arg:E21 Arg2:E22
E24	Assertion:T47 Asserted:E25
E25	Drug:T48 Name:T49 Temporality:E16
E26	Condition:T50 Name:T51
E27	Condition:T52 Name:T53
E28	Condition:T54 Name:T55
E29	Or:T56 Arg:E14 Arg2:E28
E30	Assertion:T57 Asserted:E31
E31	Drug:T58 Temporality:E32
E32	Eq-Comparison:T59 Temporal-Unit:T61 Operator:T60 Value:T21
E33	Modifier:T62 Modifies:T4
T3	Condition 69 78	infection
T4	Condition-Name 69 78	infection
T5	Life-Stage-And-Gender 25 31	Adults
T6	Condition 129 143	breast feeding
T7	Condition-Name 129 143	breast feeding
T8	Condition 116 125	Pregnancy
T9	Condition-Name 116 125	Pregnancy
T12	Condition 504 517	HIV infection
T13	Condition-Name 504 517	HIV infection
T14	Condition 519 547	systemic lupus erythematoses
T15	Condition-Name 519 547	systemic lupus erythematoses
T16	Eq-Operator 235 236	≥
T17	Eq-Operator 420 426	within
T18	Eq-Temporal-Unit 429 433	days
T19	Eq-Value 236 237	2
T20	Eq-Value 427 428	7
T21	Eq-Value 640 642	72
T22	Eq-Comparison 235 242	≥2mg/dl
T23	Eq-Comparison 420 433	within 7 days
T1	Condition 51 54	ill
T2	Severity 40 50	critically
T10	And 32 35	who
T11	Assertion 79 89	suspection
T24	And 55 58	and
T25	Or 126 128	or
T26	Allergy 156 163	allergy
T27	Drug 174 184	vancomycin
T28	Drug-Name 174 184	vancomycin
T29	Drug 188 201	ascorbic acid
T30	Drug-Name 188 201	ascorbic acid
T31	Or 185 187	or
T32	Observation 218 234	serum creatinine
T33	Observation-Name 218 234	serum creatinine
T34	Eq-Unit 237 239	mg
T35	Eq-Unit 240 242	dl
T36	Drug 274 290	nephrotoxic drug
T37	Drug-Name 274 290	nephrotoxic drug
T38	Drug-Name 298 313	aminoglycosides
T39	Drug 298 313	aminoglycosides
T40	Drug 315 329	amphotericin B
T41	Drug-Name 315 329	amphotericin B
T42	Drug 331 340	cisplatin
T43	Drug-Name 331 340	cisplatin
T44	Drug 344 366	calcinurine inhibitors
T45	Drug-Name 344 366	calcinurine inhibitors
T46	Or 341 343	or
T47	Assertion 374 385	Anticepated
T48	Drug 404 419	contrast medium
T49	Drug-Name 404 419	contrast medium
T50	Condition 480 488	diseases
T51	Condition-Name 480 488	diseases
T52	Condition 496 502	cancer
T53	Condition-Name 496 502	cancer
T54	Condition 551 571	urinary tract stones
T55	Condition-Name 551 571	urinary tract stones
T56	Or 548 550	or
T57	Assertion 579 591	Unlikelyhood
T58	Drug 615 626	medications
T59	Eq-Comparison 631 648	at least 72 hours
T60	Eq-Operator 631 639	at least
T61	Eq-Temporal-Unit 643 648	hours
T62	Modifier 64 68	MRSA
A1	Life-Stage-And-Gender-Type T5 adult
A2	Eq-Operator-Value T16 GTEQ
A3	Eq-Operator-Value T17 LTEQ
A4	Eq-Temporal-Unit-Value T18 day
A5	Severity-Value T2 severe
A6	Assertion-Type-Value E4 possible
A7	Observation-Type-Value T33 lab
A8	Assertion-Type-Value E24 hypothetical
A9	Assertion-Type-Value E30 hypothetical
A10	Eq-Operator-Value T60 LTEQ
A11	Eq-Temporal-Unit-Value T61 hour
R1	Example-Of Arg1:E19 Arg2:E18
R2	Example-Of Arg1:E20 Arg2:E18
R3	Example-Of Arg1:E21 Arg2:E18
R4	Example-Of Arg1:E22 Arg2:E18
R5	Example-Of Arg1:E27 Arg2:E26
R6	Example-Of Arg1:E12 Arg2:E26
R7	Example-Of Arg1:E14 Arg2:E26
R8	Example-Of Arg1:E28 Arg2:E26
